HKSE:02252 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:02252 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), Shanghai MicroPort MedBot (Group) Co's share price is HK$13.68. Shanghai MicroPort MedBot (Group) Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.59. Hence, Shanghai MicroPort MedBot (Group) Co's PB Ratio of today is 23.07.
The historical rank and industry rank for Shanghai MicroPort MedBot (Group) Co's PB Ratio or its related term are showing as below:
During the past 5 years, Shanghai MicroPort MedBot (Group) Co's highest PB Ratio was 27.66. The lowest was 6.44. And the median was 11.74.
During the past 12 months, Shanghai MicroPort MedBot (Group) Co's average Book Value Per Share Growth Rate was -64.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -30.90% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai MicroPort MedBot (Group) Co was 276.30% per year. The lowest was -30.90% per year. And the median was 122.70% per year.
The historical data trend for Shanghai MicroPort MedBot (Group) Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
PB Ratio | - | - | 19.15 | 19.25 | 35.16 |
Shanghai MicroPort MedBot (Group) Co Semi-Annual Data | |||||||||
Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | |
PB Ratio | Get a 7-Day Free Trial | 19.15 | 12.77 | 19.25 | 22.33 | 35.16 |
For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Shanghai MicroPort MedBot (Group) Co's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Dec. 2023) |
= | 13.68 | / | 0.593 | |
= | 23.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
He Chao | 2201 Interest of corporation controlled by you | |
Yuan Shuai | 2201 Interest of corporation controlled by you | |
Ji Shufang | 2202 Interest of your spouse | |
Wu Kaili | 2202 Interest of your spouse | |
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd. | 2201 Interest of corporation controlled by you | |
Shenzhen Gao Ling Muqi Equity Investment Fund Llp | 2201 Interest of corporation controlled by you | |
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp | 2201 Interest of corporation controlled by you | |
Zhuhai Gao Ling Chongheng Equity Investment Llp | 2101 Beneficial owner | |
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo | 2103 Interests held jointly with another person | |
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si | 2103 Interests held jointly with another person | |
Wei Chuang Yi Liao Ke Xue You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo | 2101 Beneficial owner |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.